Revenue: The sum of all revenue fields included for a company's operating activities.
Agios Pharmaceuticals, Inc. (AGIO) had Revenue of $19.97M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
|
Revenue |
$19.97M |
$-108.04M |
|
$1.88M |
|
$18.09M |
|
$141.54M |
|
$-121.58M |
|
$12.52M |
|
$-109.06M |
|
$-109.06M |
|
$-108.04M |
|
$-108.04M |
|
$-108.04M |
|
$-108.04M |
|
$-121.58M |
|
$-122.06M |
|
57.97M |
|
57.97M |
|
$-1.86 |
|
$-1.86 |
|
| Balance Sheet Financials | |
$942.05M |
|
$10.78M |
|
$355.17M |
|
$1.30B |
|
$82.21M |
|
-- |
|
$21.91M |
|
$104.11M |
|
$1.19B |
|
$1.19B |
|
$1.19B |
|
58.45M |
|
| Cash Flow Statement Financials | |
$-372.98M |
|
$377.18M |
|
$8.68M |
|
$76.25M |
|
$89.13M |
|
$12.88M |
|
$52.55M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
11.46 |
|
-- |
|
-- |
|
-- |
|
-- |
|
90.59% |
|
-608.89% |
|
-608.89% |
|
-- |
|
-546.18% |
|
-541.09% |
|
$-377.29M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
0.06 |
|
1.89 |
|
47.68 |
|
-9.06% |
|
-9.06% |
|
-8.33% |
|
-9.06% |
|
$20.41 |
|
$-6.51 |
|
$-6.43 |
|